Maverix Biomics scores $6 mln in Series A funds
Maverix Biomics said Tuesday that it has secured $6 million in Series A funding. The round was co-led by Asset Management Ventures, Andreas Bechtolsheim and Dr. Andrew Yang. As a result of the financing, Dr. Louis G. Lange, a general partner at Asset Management Ventures and Dr. Yang have joined the company's board. Based in San Mateo, Calif., Maverix Biomics is a provider of solutions for next-generation sequencing genomic data analysis.
7 January 2014•4 mins read
